COST Action CA18218

16th European Public Health Conference

eph2023 group photo 02 wide

The 16th European Public Health Conference, organised by the European Public Health Association (EUPHA), took place from 9 to 11 November 2023, with pre-conferences organised on 8 November. The conference was held at the Convention Centre Dublin, Ireland. Complete information about the congress is available via https://ephconference.eu/.

During the conference, our COST Action contributed to live workshops on burden of disease assessment. There were also several abstract and poster presentations on burden of disease by our network members. Below you will find an overview of the different burden of disease sessions held at the 16th European Public Health Conference.

Burden of disease workshops and skills building seminars

Workshop: Data, tools and methodologies on injury burden in Europe: current limitations and future directions
Fri 10/11, 15h10-16h10  •  View the abstract
A new Norwegian Injury Registration System as a starting point to assess the burden of injuries in Norway
— Johan Lund, NIPH, Norway
View the abstract
Barriers in the implementation of burden of disease estimates in Belgium and potential solutions
— Robby De Pauw, Sciensano, Belgium
View the abstract
Data collection and analysis on the burden of injuries: Lessons learned from the IDB network
— Robert Bauer, Austria
View the abstract
Methodological challenges in collecting and analysing data on child unintentional injuries: Insights from the CHILD Vigilance project (CHIVI) on parents’ attitudes and practices
— Tatiana Alves, Portugal
View the abstract
Workshop: Projecting future burden of disease for informed public health decision making
Sat 11/11, 11h40-12h40  •  View the abstract
Disease burden in Norway in 2050: A forecasting analysis based on the Global Burden of Disease (GBD) Study
— Ann Kristin Knudsen, NIPH, Norway
View the abstract
Future Dutch DALYs as part of the Dutch Public health Foresight Study
— Henk Hilderink, RIVM, Netherlands
View the abstract
Forecasting the future burden of disease in Scotland
— Ian Grant, Public Health Scotland, UK
View the abstract
Disease burden in Belgium in 2040: Methodological considerations
— Robby De Pauw, Sciensano, Belgium
View the abstract
Workshop: Risk-benefit assessment of foods and diets for a sustainable future
Sat 11/11, 14h00-15h00  •  View the abstract
Risk-benefit assessment of foods – status, challenges, and opportunities
— Sofie Theresa Thomsen, DTU, Denmark
View the abstract
Holistic approaches for risk-benefit assessment
— Constanza De Matteu Monteiro, DTU, Denmark
View the abstract
Exploring subjective risk-benefit perception as an integral component in risk communication
— Mark Lohmann, BfR, Germany
View the abstract
The World Health Organization endeavours to put forward integrated approaches to food and diet risk-benefit assessment
— Moez Sanaa, World Health Organization, Switzerland
View the abstract

Burden of disease abstract presentations

Thursday 9 November 2023
9h00–10h00 1.E. - Oral presentations: Air pollution Local approach to attributable disease burden: case study for air pollution and mortality in Belgium
Arno Pauwels - Belgium
View the abstract
9h00–10h00 1.R. - Reducing health inequity Sociodemographic features of COVID-19 premature mortality: Serbian individual-level data evidence
Aleksandar Stevanović - Serbia
View the abstract
10h30–11h30 2.E. - Workshop: Salutogenic Cities: European experiences in Urban Health The urban burden of disease estimation for policy-making in 1000 European cities
Vlatka Matkovic - Belgium
View the abstract
10h30–11h30 2.R. - Poster walk: Chronic diseases The burden of breast cancer attributable to modifiable risk factors
Jovana Todorovic - Serbia
View the abstract
10h30–11h30 2.R. - Poster walk: Chronic diseases Assessing and projecting the burden of diabetes mellitus in the European Union by 2030
Nour Mahrouseh - Hungary
View the abstract
16h40–17h40 4.B. - Pitch presentations: One Health, infectious diseases Disease costs due to outdoor ambient particulate matter pollution in Germany, 2018
Dietrich Plass - Germany
View the abstract
16h40–17h40 4.E. - Pitch presentations: Environment and health The burden of ischemic stroke due to air pollution in ten European countries
Katarina Vojvodic - Serbia
View the abstract
Friday 10 November 2023
11h40–12h40 6.D. - Pitch presentations: The burden of chronic diseases Subnational inequalities in YLLs and associated socioeconomic factors: a disease burden study
Carl Baravelli - Norway
View the abstract
11h40–12h40 6.R. - Poster walk: Epidemiology Sex differences in disease burden in Norway: an analysis of the Global Burden of Disease Study 2019
Ingeborg Forthun - Norway
View the abstract
11h40–12h40 6.R. - Poster walk: Epidemiology Mortality burden due to COVID-19 in 14 countries or regions in Southeastern Europe and Central Asia
Caoimhe Cawley - Germany
View the abstract
15h10–16h10 7.R. - Poster walk: Epidemiology 2 Burden of dementia, chronic kidney and cardiovascular diseases attributable to hypertension in France
Clemence Grave - France
15h10–16h10 7.R. - Poster walk: Epidemiology 2 The burden of cardiovascular disease associated with PM2.5 exposure in the Portuguese population
Carla Martins - Portugal
View the abstract
Saturday 11 November 2023
9h00–10h00 9.A. - Pitch presentations: Healthy diets The burden of dietary risk factors in the Nordic and Baltic countries
Ann Kristin Knudsen - Norway
View the abstract
9h00–10h00 9.G. - Oral presentations: Health assessments: impact, technology Health impact assessment of the chemical exposome in European children
Audrey Rocabois - France
View the abstract
9h00–10h00 9.S. - COVID-19 experiences Which burden of COVID-19 was greater: main diagnosis or comorbidity?
Milena Šantrić Milićević - Serbia
View the abstract
9h00–10h00 9.S. - COVID-19 experiences Years Lived with Disability due to COVID-19 in the capital of Serbia in 2020 and 2021
Natasa Rosic - Serbia
View the abstract
11h40–12h40 10.D. - Oral presentations: Prevention and management of chronic diseases Burden of T1DM and T2DM among adolescents in Western Europe, 1990-2019: results from the GBD 2019
Benedetta Armocida - Italy
View the abstract
11h40–12h40 10.L. - Oral presentations: Understanding population health Estimating the burden of Long COVID symptom clusters in Ireland
Tochukwu Igboanugo - Ireland
View the abstract
13h50–14h50 11.O. - Oral presentations: Child and adolescent health Quantifying the environmental burden of disease for children and adolescents in Germany
Dietrich Plass - Germany
View the abstract

Burden of disease poster displays

DF - Chronic diseases DF.39 - DALY attributable to air pollution associated with tracheal, bronchus, and lung cancer in Europe
Katarina Vojvodic - Serbia
View the abstract
DJ - Epidemiology DJ.23 - Patterns in tobacco attributed mortality in Belgium for 2019
Leonor Guariguata - Belgium
View the abstract
DJ - Epidemiology D.46 - Burden of heart failure in Kazakhstan: data from the unified national healthcare system 2014-2021
Gulnur Zhakhina - Kazakhstan
View the abstract
DU - Policy, politics and public health DU.5 - Burden Estimation of SAR-CoV-2 (COVID-19) in Ireland over the First Full two years of the pandemic
Tochukwu Igboanugo - Ireland
View the abstract

About COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. COST Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. Read more via cost.eu.

Get in touch

COST logo

Funded by the European Union

Website by  woluweb mini